Genomics inked a partnership deal with fellow U.K.-based biotech Greywolf Therapeutics to organize and evaluate ERAP enzymes and how they influence autoimmune disease risks.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Genomics inked a partnership deal with fellow U.K.-based biotech Greywolf Therapeutics to organize and evaluate ERAP enzymes and how they influence autoimmune disease risks.